Natural history of untreated renal cell carcinoma with venous tumor thrombus

被引:141
|
作者
Reese, Adam C. [1 ]
Whitson, Jared M. [1 ]
Meng, Maxwell V. [1 ,2 ]
机构
[1] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA
[2] Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
关键词
Carcinoma; Renal cell; Vena cava; Inferior; Survival; VENA-CAVA INVOLVEMENT; PROGNOSTIC-SIGNIFICANCE; SURGICAL-MANAGEMENT; EXTENSION; VEIN; NEPHRECTOMY; EXPERIENCE; SURVIVAL; SURGERY; CANCER;
D O I
10.1016/j.urolonc.2011.12.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: The natural history of untreated renal cell carcinoma (RCC) with venous tumor thrombus (VTT) is poorly characterized. We aimed to describe the natural history of this disease, and to identify prognostic factors associated with disease-specific survival. Materials and methods: We identified patients in the Surveillance, Epidemiology, and End Results (SEER) database with untreated renal cell carcinoma and venous tumor thrombi. Disease-specific median and 1-year survival rates were determined, and disease-free survival curves were plotted using the Kaplan-Meier method. Multivariable Cox regression analyses were performed to identify factors associated with disease-specific and overall survival in this patient group. Results: Of 2,265 patients with RCC and VTT, 390 (17%) underwent no treatment; 278 (71%) patients died during follow-up; of these, 243 deaths (87%) were due to RCC. Median and 1-year disease-specific survival for this group was 5 months and 29%, respectively. On multivariable analysis, the extent of tumor thrombus (HR 1.7 for T3c vs. T3b, 95% CI 1.0-2.7) and the presence of metastases (HR 3.1 for M+ vs. MO, 95% CI 1.7-5.5) were most strongly associated with disease-specific mortality. Conclusions: Prognosis is poor for the majority of untreated patients with RCC and VTT. Supradiaphragmatic thrombi and distant metastases are adverse prognostic factors in this patient group. This information is important when counseling patients as to the risk and benefits of surgical vs. nonoperative management of RCC and VTT. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:1305 / 1309
页数:5
相关论文
共 50 条
  • [1] Clinical management of renal cell carcinoma with venous tumor thrombus
    Nnenaya Agochukwu
    Brian Shuch
    World Journal of Urology, 2014, 32 : 581 - 589
  • [2] Genomic features of renal cell carcinoma with venous tumor thrombus
    Gregor Warsow
    Daniel Hübschmann
    Kortine Kleinheinz
    Cathleen Nientiedt
    Martina Heller
    Laura Van Coile
    Yanis Tolstov
    Lukas Trennheuser
    Kathrin Wieczorek
    Carine Pecqueux
    Claudia Gasch
    Timur Kuru
    Joanne Nyarangi-Dix
    Gencay Hatiboglu
    Dogu Teber
    Sven Perner
    Albrecht Stenzinger
    Wilfried Roth
    Boris Hadaschik
    Sascha Pahernik
    Dirk Jäger
    Carsten Grüllich
    Anette Duensing
    Roland Eils
    Matthias Schlesner
    Holger Sültmann
    Markus Hohenfellner
    Stefan Duensing
    Scientific Reports, 8
  • [3] Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus
    Abel, E. Jason
    Spiess, Philippe E.
    Margulis, Vitaly
    Master, Viraj A.
    Mann, Michael
    Zargar-Shoshtari, Kamran
    Borregales, Leonardo D.
    Sexton, Wade J.
    Patil, Datta
    Matin, Surena F.
    Wood, Christopher G.
    Karam, Jose A.
    JOURNAL OF UROLOGY, 2017, 198 (02): : 281 - 288
  • [4] Prognostic value of venous tumor thrombus in renal cell carcinoma
    Garcia-Fadrique, G.
    Budia-Alba, A.
    Ruiz-Cerda, J. L.
    Morales-Solchaga, G.
    Pontones, J. L.
    Jimenez-Cruz, J. F.
    ACTAS UROLOGICAS ESPANOLAS, 2012, 36 (01): : 29 - 34
  • [5] Genomic features of renal cell carcinoma with venous tumor thrombus
    Warsow, Gregor
    Huebschmann, Daniel
    Kleinheinz, Kortine
    Nientiedt, Cathleen
    Heller, Martina
    Van Coile, Laura
    Tolstov, Yanis
    Trennheuser, Lukas
    Wieczorek, Kathrin
    Pecqueux, Carine
    Gasch, Claudia
    Kuru, Timur
    Nyarangi-Dix, Joanne
    Hatiboglu, Gencay
    Teber, Dogu
    Perner, Sven
    Stenzinger, Albrecht
    Roth, Wilfried
    Hadaschik, Boris
    Pahernik, Sascha
    Jaeger, Dirk
    Gruellich, Carsten
    Duensing, Anette
    Eils, Roland
    Schlesner, Matthias
    Sueltmann, Holger
    Hohenfellner, Markus
    Duensing, Stefan
    SCIENTIFIC REPORTS, 2018, 8
  • [6] Clinical management of renal cell carcinoma with venous tumor thrombus
    Agochukwu, Nnenaya
    Shuch, Brian
    WORLD JOURNAL OF UROLOGY, 2014, 32 (03) : 581 - 589
  • [7] Immunogenic Heterogeneity of Renal Cell Carcinoma With Venous Tumor Thrombus
    Liss, Michael A.
    Chen, Yidong
    Rodrigue, Ronald
    Pruthi, Deepak
    Johnson-Pais, Teresa
    Wang, Hanzhang
    Mansour, Ahmed
    Kaushik, Dharam
    UROLOGY, 2019, 124 : 168 - 173
  • [8] Bibliometric analysis of renal cell carcinoma with venous tumor thrombus
    Xu, Jinbin
    Lee, Weijen
    Yang, Shoudong
    Gao, Shuntian
    Ye, Yuedian
    Deng, Gengguo
    Zhang, Weixing
    Di, Jinming
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2024, 21 (11): : 2094 - 2108
  • [9] The Adverse Survival Implications of Bland Thrombus in Renal Cell Carcinoma With Venous Tumor Thrombus
    Hutchinson, Ryan
    Rew, Charles
    Chen, Gong
    Woldu, Solomon
    Krabbe, Laura-Maria
    Meissner, Matthew
    Sheth, Kunj
    Singla, Nirmish
    Shakir, Nabeel
    Master, Viraj A.
    Karam, Jose A.
    Matin, Surena F.
    Borregales, Leonardo D.
    Wood, Christopher
    Masterson, Timothy
    Thompson, R. Houston
    Boorjian, Stephen A.
    Leibovich, Bradley C.
    Abel, E. Jason
    Bagrodia, Aditya
    Margulis, Vitaly
    UROLOGY, 2018, 115 : 119 - 124
  • [10] Comment to "Prognostic Value of Venous Tumor Thrombus in Renal Cell Carcinoma"
    Fernandez, E.
    ACTAS UROLOGICAS ESPANOLAS, 2012, 36 (01): : 35 - 36